Pall Corporation (
),a global manufacturer of filtration,separation and purification
products,recently announced its intention to open an innovative
Life Sciences Centre of Excellence (COE) in Portsmouth in the
U.K. This COE will be located at Pall's new Harbourgate site and
is expected to be operational in mid 2013.
The new COE will provide a complete range of advanced
facilities, including cell culture, purification, analytical
solutions, protein characterization and microbiological tools. It
will complement Pall's other Life Sciences Centers in the U.S.
(Westborough, MA and Menlo Park, CA) and other investments in
China, Singapore, and India.
Pall's Life Science segment is focused on developing,
manufacturing and selling products to customers in the Medical
and Bio Pharmaceuticals marketplaces. The new Portsmouth COE is
an extension of Pall's Life Science segment and will enable it to
better serve its customers. It will have a wide scientific area
to house its scientists and engineers and will provide improved
customer service support with a better environment and extended
facilities. The COE will develop, test and validate a wide range
of Pall's new product portfolio.
Last quarter, Pall missed the Zacks Earnings Estimates by
Tetra Tech Inc.
) performed better. In such a scenario, with the absence of any
meaningful general business expansion, margin improvements are
likely to be made by the addition of new products or processes.
These in turn are likely to emerge from research laboratories.
Consequently, this new COE was enthusiastically pursued by
Pall currently has a Zacks Rank # 3 (Hold), while
) has a better Rank, Zacks Rank # 2.
CALGON CARBON (CCC): Free Stock Analysis
HAEMONETICS CP (HAE): Free Stock Analysis
PALL CORP (PLL): Free Stock Analysis Report
TETRA TECH NEW (TTEK): Free Stock Analysis
To read this article on Zacks.com click here.